Laurion Capital Management’s Immunic IMUX Stock Holding History

Laurion Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.31M	Hold	388,216	–	–	0.19%	145
2025 Q4	$2.07M	Buy	388,216 +200,000	+106%	+$1.47M	0.08%	105
2025 Q3	$1.66M	Sell	188,216 -2,290	-1%	-$20.2K	0.03%	169
2025 Q2	$1.33M	Buy	190,506 +167,663	+734%	+$1.54M	0.02%	189
2025 Q1	$249K	Buy	+22,843	New	+$247K	0.01%	223
2014 Q4	–	Sell	-29	Closed	-$241K	–	377
2014 Q3	$241K	Sell	29 -8	-22%	-$75.5K	0.01%	248
2014 Q2	$406K	Buy	+37	New	+$260K	0.01%	240

Other funds holding IMUX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Laurion Capital Management's IMUX Position: Q1 2026 in Review

Laurion Capital Management held its Immunic (IMUX) position steady in Q1 2026 at 388,216 shares worth $4.31M. The position accounts for 0.19% of the portfolio, ranked #145.

Laurion Capital Management first reported a position in IMUX in Q2 2014 and has held it in 7 quarters since. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

Laurion Capital Management held 388,216 shares of Immunic worth $4.31M as of Q1 2026.
Laurion Capital Management left its Immunic share count unchanged in Q1 2026.
Immunic made up 0.19% of Laurion Capital Management's portfolio in Q1 2026, its #145 holding.
Laurion Capital Management first reported a position in Immunic in Q2 2014 and has held it in 7 quarters since.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.